Effect of ferrate, a site-specific phosphate analog, on human deoxyhemoglobin.
Ferrate ion, a phosphate analog and a potent oxidizing agent, is known to inactivate a number of enzymes which interact with phosphoryl compounds. In contrast, enzymes which do not interact with phosphoryl compounds are not affected by comparable concentrations of ferrate. To further explore the specificity of ferrate as a reagent which is specific for phosphoryl binding sites, a study of its effect on human hemoglobin A was undertaken. In the deoxy form, this protein is known to interact with 2,3-bisphosphoglycerate, its natural allosteric inhibitor of cooperative binding of oxygen, while as oxyhemoglobin it does not interact with the inhibitor. Treatment with ferrate ion caused the loss of approximately three amino acid residues per beta chain of human deoxyhemoglobin, His-2, His-143, and Tyr-145, and one residue, presumably Tyr-42, per alpha chain. Oxyhemoglobin was not affected by the reagent. 2,3-Bisphosphoglycerate was found to protect deoxyhemoglobin from the action of ferrate. His-2 and His-143 are among the residues reported to be implicated in the binding of 2,3-bisphosphoglycerate by deoxyhemoglobin [A. Arnone (1972) Nature (London) 237, 146-148].
D019794:2,3-Diphosphoglycerate; D000595:Amino Acid Sequence; D000596:Amino Acids / Q000032:analysis; D001665:Binding Sites / Q000187:drug effects; D055598:Chemical Phenomena; D002621:Chemistry; D004163:Diphosphoglyceric Acids / Q000097:blood; D006454:Hemoglobins / Q000378:metabolism*; D006801:Humans; D007202:Indicators and Reagents; D010710:Phosphates / Q000097:blood*; D011485:Protein Binding
D000596:Amino Acids; D004163:Diphosphoglyceric Acids; D006454:Hemoglobins; D007202:Indicators and Reagents; D010710:Phosphates; D019794:2,3-Diphosphoglycerate; C100003:deoxyhemoglobin